SEC14L3 and nonpapillary renal cell carcinoma: Moreover, Kaplan‒Meier survival analysis of the TCGA cohort revealed a compelling association between elevated SEC14L3 expression in ccRCC patients and markedly shorter overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS) durations (Fig. 1e–g).